News

  • ExB Labs and Alacris Theranostics Announce Strategic Collaboration

    19 June 2017  – ExB Labs and Alacris Theranostics today announced that they have entered into a strategic collaboration to combine ExB’s AI machine learning platform, “Cognitive Workbench” with Alacris’ “deep omics” analysis capabilities and its unique predictive modeling system, ModCell™. Joining forces and technologies, both companies aim to automate…

    Read more
  • FAZ: ExB named as ground-breaking German AI firm

    The leading German daily newspaper Frankfurter Allgemeine Zeitung reviewed the German AI industry in its 22 April 2017 issue, naming ExB, along with Celonis and Scopevisio as ground-breaking German firms working in this key field. The article highlights how data mining, deep learning and artificial intelligence are not only “the next…

    Read more
  • ExB invited by ZD.B to speak about Big Data Driven Healthcare

    Dr. Ramin Assadollahi, CEO of ExB Labs and ExB Health, is invited to participate at the upcoming event “The Future of Healthcare”. The event is organized by ZD.B (Zentrum Digitalisierung Bayern). Dr. Assadollahi will talk about “Which problems in healthcare AI can solve – and which not“. The organizers ask: “Where do…

    Read more
  • Dr. Ramin Assadollahi to talk on Smart Data panel of BMWi at CeBIT 2017

    20.03.2017 – Dr. Ramin Assadollahi, CEO and Founder ExB Group, is invited to participate as an external expert on a panel discussion about “How and what to learn from Big Data – challenges and recommendations” at CeBIT 2017. The panel takes place at “Forum des BMWi”, hall 6, booth C40 on…

    Read more
  • Dr. Peter Neubeck speaks at BIO-Europe Conference

    04.11.2016 – Dr. Peter Neubeck, Chief Medical Officer at ExB, is invited to speak at BIO-Europe in Cologne. BIO-Europe is Europe’s largest partnering conference serving the global biotechnology industry. Dr. Neubeck will be talking at the panel discussion”Big Pharma’s approach to digital medicine” on Monday Nov 7. The convergence of new technologies and therapies…

    Read more